Twin studies reveal specific imbalances in the mucosa‐associated microbiota of patients with ileal Crohn's disease

Background: Large interindividual variation in the composition of the intestinal microbiota between unrelated individuals has made it challenging to identify specific aspects of dysbiosis that lead to Crohn's disease (CD). Methods: To reduce variations in exposure during establishment of the gut flora and the influence of genotype, we studied the mucosa‐associated microbiota of monozygotic twin pairs that were discordant (n = 6) or concordant (n = 4) for CD. DNA was extracted from biopsies collected from 5 locations between the ileum and rectum. Bacterial 16S ribosomal RNA genes were amplified and community composition assessed by terminal‐restriction fragment length polymorphism, cloning and sequencing, and quantitative real‐time polymerase chain reaction (PCR). Results: The microbial compositions at all biopsy locations for each individual were similar, regardless of disease state, but there were differences between individuals. In particular, individuals with predominantly ileal CD had a dramatically lower abundance (P < 0.001) of Faecalibacterium prausnitzii and increased abundance (P < 0.03) of Escherichia coli compared to healthy co‐twins and those with CD localized in the colon. This dysbiosis was significantly correlated to the disease phenotype rather than genotype. Conclusions: The reduced abundance of F. prausnitzii and increased abundance of E. coli are indicative of an ileal CD phenotype, distinct from colonic CD, and the relative abundances of these specific bacterial populations are promising biomarker candidates for differential diagnosis of CD and eventually customized treatment.

[1]  R. Sartor.  Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitis , 2006, Nature Clinical Practice Gastroenterology &Hepatology.

[2]  C. Manichanh,et al.  Review article: the role of bacteria in onset and perpetuation of inflammatory bowel disease , 2006, Alimentary pharmacology & therapeutics.

[3]  N. Pace,et al.  Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases , 2007, Proceedings of the National Academy of Sciences.

[4]  E. Zoetendal,et al.  Mucosa-Associated Bacteria in the Human Gastrointestinal Tract Are Uniformly Distributed along the Colon and Differ from the Community Recovered from Feces , 2002, Applied and Environmental Microbiology.

[5]  J. Garcia-Gil,et al.  Abnormal microbiota composition in the ileocolonic mucosa of Crohn's disease patients as revealed by polymerase chain reaction‐denaturing gradient gel electrophoresis , 2006, Inflammatory bowel diseases.

[6]  Laurent Beaugerie,et al.  High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. , 2004, Gastroenterology.

[7]  J. Hampe,et al.  Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease , 2004, Gut.

[8]  A. Uitterlinden,et al.  Profiling of complex microbial populations by denaturing gradient gel electrophoresis analysis of polymerase chain reaction-amplified genes coding for 16S rRNA , 1993, Applied and environmental microbiology.

[9]  R. F. Harvey,et al.  A SIMPLE INDEX OF CROHN'S-DISEASE ACTIVITY , 1980, The Lancet.

[10]  Neil Hunter,et al.  Determination of bacterial load by real-time PCR using a broad-range (universal) probe and primers set. , 2002, Microbiology.

[11]  J. Jansson,et al.  Molecular analysis of the gut microbiota of identical twins with Crohn's disease , 2008, The ISME Journal.

[12]  F. Shanahan,et al.  Culture-Independent Analyses of Temporal Variation of the Dominant Fecal Microbiota and Targeted Bacterial Subgroups in Crohn's Disease , 2006, Journal of Clinical Microbiology.

[13]  H. Flint,et al.  The microbiology of butyrate formation in the human colon. , 2002, FEMS microbiology letters.

[14]  A. Murray,et al.  Investigations into the influence of host genetics on the predominant eubacteria in the faecal microflora of children. , 2005, Journal of medical microbiology.

[15]  C. Neut,et al.  Self inflicted rectal ulcer: hearing is believing , 2003, Gut.

[16]  M. Weichenthal,et al.  Reduced Paneth Cell &agr;-Defensins and Antimicrobial Activity in Ileal Crohn's Disease , 2006 .

[17]  D. Rampton,et al.  Molecular Characterization of Rectal Mucosa‐Associated Bacterial Flora in Inflammatory Bowel Disease , 2005, Inflammatory bowel diseases.

[18]  S. Hanauer,et al.  Inflammatory bowel disease: Epidemiology, pathogenesis, and therapeutic opportunities , 2006, Inflammatory bowel diseases.

[19]  J. Doré,et al.  Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon , 2003, Gut.

[20]  C. Manichanh,et al.  Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach , 2005, Gut.

[21]  D. Relman,et al.  The role of microbes in Crohn's disease. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  Martin Wiedmann,et al.  Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum , 2007, The ISME Journal.

[23]  H. Harmsen,et al.  Growth requirements and fermentation products of Fusobacterium prausnitzii, and a proposal to reclassify it as Faecalibacterium prausnitzii gen. nov., comb. nov. , 2002, International journal of systematic and evolutionary microbiology.

[24]  H. Lochs,et al.  Spatial Organization and Composition of the Mucosal Flora in Patients with Inflammatory Bowel Disease , 2005, Journal of Clinical Microbiology.

[25]  J. Doré,et al.  Molecular inventory of faecal microflora in patients with Crohn's disease. , 2003, FEMS microbiology ecology.

[26]  U. Gophna,et al.  Differences between Tissue-Associated Intestinal Microfloras of Patients with Crohn's Disease and Ulcerative Colitis , 2006, Journal of Clinical Microbiology.

[27]  E. Lindberg,et al.  Inflammatory bowel disease in a Swedish twin cohort: a long-term follow-up of concordance and clinical characteristics. , 2003, Gastroenterology.

[28]  J. Marshall,et al.  Increased intestinal permeability precedes the onset of Crohn's disease in a subject with familial risk. , 2000, Gastroenterology.

[29]  W. Scheppach,et al.  The butyrate story: old wine in new bottles? , 2004, Current opinion in clinical nutrition and metabolic care.

[30]  A. Cohen,et al.  Combined budesonide and antibiotic therapy for active Crohn's disease: a randomized controlled trial. , 2001, Gastroenterology.

[31]  G. Pershagen,et al.  Molecular Fingerprinting of the Fecal Microbiota of Children Raised According to Different Lifestyles , 2007, Applied and Environmental Microbiology.

[32]  G. Macfarlane,et al.  Mucosa-Associated Bacterial Diversity in Relation to Human Terminal Ileum and Colonic Biopsy Samples , 2007, Applied and Environmental Microbiology.

[33]  R Balfour Sartor,et al.  Microbial influences in inflammatory bowel diseases. , 2008, Gastroenterology.

[34]  R. Briers,et al.  Ecology: From Individuals to Ecosystems , 2006 .

[35]  N. Barnich,et al.  Adherent-invasive Escherichia coli and Crohn's disease , 2007, Current opinion in gastroenterology.

[36]  J. Doré,et al.  Patchy distribution of mucosal lesions in ileal Crohn's disease is not linked to differences in the dominant mucosa‐associated bacteria: A study using fluorescence in situ hybridization and temporal temperature gradient gel electrophoresis , 2007, Inflammatory bowel diseases.

[37]  H. Blöcker,et al.  Isolation and direct complete nucleotide determination of entire genes. Characterization of a gene coding for 16S ribosomal RNA. , 1989, Nucleic acids research.

[38]  S. Edwards,et al.  Replication of Colonic Crohn's Disease Mucosal Escherichia coli Isolates within Macrophages and Their Susceptibility to Antibiotics , 2007, Antimicrobial Agents and Chemotherapy.

[39]  Mario Vaneechoutte,et al.  Active Crohn's disease and ulcerative colitis can be specifically diagnosed and monitored based on the biostructure of the fecal flora , 2008, Inflammatory bowel diseases.

[40]  M. Kagnoff,et al.  Cell Differentiation Is a Key Determinant of Cathelicidin LL-37/Human Cationic Antimicrobial Protein 18 Expression by Human Colon Epithelium , 2002, Infection and Immunity.

[41]  Philippe Marteau,et al.  Specificities of the fecal microbiota in inflammatory bowel disease , 2006, Inflammatory bowel diseases.

[42]  Shadi Sepehri,et al.  High prevalence of Escherichia coli belonging to the B2+D phylogenetic group in inflammatory bowel disease , 2006, Gut.

[43]  P. Gerner-Smidt,et al.  Invasive Escherichia coli are a feature of Crohn's disease , 2007, Laboratory Investigation.

[44]  J. Genschel,et al.  Genetic basis for increased intestinal permeability in families with Crohn’s disease: role of CARD15 3020insC mutation? , 2005, Gut.

[45]  P. Rutgeerts,et al.  Predictability of the postoperative course of Crohn's disease. , 1990, Gastroenterology.

[46]  J. Doré,et al.  Biodiversity of the Mucosa‐Associated Microbiota Is Stable Along the Distal Digestive Tract in Healthy Individuals and Patients With Ibd , 2005, Inflammatory bowel diseases.

[47]  H. Steinhart,et al.  Combination ciprofloxacin and metronidazole for active Crohn's disease. , 1998, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[48]  C. Hart,et al.  Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. , 2004, Gastroenterology.

[49]  Haifeng Lu,et al.  Symbiotic gut microbes modulate human metabolic phenotypes , 2008, Proceedings of the National Academy of Sciences.

[50]  Willem M. de Vos,et al.  The Host Genotype Affects the Bacterial Community in the Human Gastrointestinal Tract , 2001 .

[51]  John L. Harper,et al.  Ecology from individuals to ecosystems 4th ed. , 2008 .

[52]  R. Bibiloni,et al.  The bacteriology of biopsies differs between newly diagnosed, untreated, Crohn's disease and ulcerative colitis patients. , 2006, Journal of medical microbiology.